What TransVoyant does

TransVoyant is a private Alexandria, Virginia-based software company that builds and operates the Continuous Decision Intelligence (CDI) Platform — a deterministic, physics-based supply chain intelligence system. The core CDI Nucleus engine applies proprietary mathematical frameworks (algebraic constraints and continuous calculus rather than stochastic probability models) to model the physical behavior of global supply chains in real time, processing billions of daily events across 284,700 active nodes and 142,000 risk vectors with 12ms latency. A 13-year corpus of cleansed, normalized, anonymized behavioral telemetry from IoT sensors, port telematics, weather radar, manufacturing execution systems, and external threat vectors provides Day 1 inherited intelligence to new customers. The platform operates across four application domains: Predictive Visibility & Risk, Precision Execution & Orchestration, High Fidelity Continuous Optimization, and Adaptive Compliance & Sustainability, supported by over 100 pre-built capability blades and a low-code Innovation Foundry for custom applications.

The company serves exclusively Fortune 50 enterprise customers across life sciences/pharmaceutical (MSD/Merck, Pfizer, Eli Lilly, McKesson), automotive (Bridgestone, Ford, Nissan), telecommunications equipment, and defense/government verticals. Documented outcomes include MSD saving 3 million+ vaccine doses from thermal destruction through predictive interdiction, a 90% reduction in MSD manual planning headcount (40 to 4 planners), and millions in detention and demurrage fees saved for Bridgestone. The Mission Services layer includes 24/7 Global Command Center overwatch across four continents, White Glove Interdiction (human-in-the-loop carrier negotiation and rebooking), a Rapid Engineering unit, and a national-security-grade IV&V Proving Ground for sensor and logistics provider validation.

TransVoyant operates a SaaS/PaaS subscription model augmented by professional services, with multi-year enterprise contracts on a custom-quoted basis — no public pricing is disclosed. The go-to-market deliberately avoids traditional trade shows in favor of the proprietary 'Off The Record' invite-only peer community following Chatham House Rules. The company has scaled globally without venture capital, holding only three aligned investors (Merck Global Health Innovation Fund, In-Q-Tel, and senior national security individuals), with $8.7M raised of a $25M exempt offering filed in December 2022. Certifications include SOC 2 Type II, GDPR (first in domain), EU-U.S./UK/Swiss Data Privacy Framework, and HIPAA.

Name

TransVoyant

Legal name

TransVoyant, Inc.

Website

https://transvoyant.com

Company type

Private

Founded year

2013

Operating status

Operating

Headcount range

11–50 employees

Short description

TransVoyant builds the CDI Platform, a deterministic physics-based supply chain intelligence engine serving Fortune 50 enterprises in pharmaceutical, automotive, and defense verticals with predictive interdiction and 24/7 global mission services.

Ownership category

akta.pro rank

Headquarters

HQ city

Alexandria

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Infrastructure, Personnel, Operations, Marketing or Sales

Revenue model

1. SaaS/PaaS Platform Subscription: The company operates as a SaaS and PaaS provider delivering the CDI Platform on a subscription basis. Revenue is generated through recurring platform fees with deployment, data management, security, compliance, and upgrades managed by TransVoyant.
2. Mission Services: Premium human-driven services including 24/7 Global Command Center overwatch, White Glove Interdiction for mission-critical assets, and Rapid Engineering unit for custom application development. Professional services complement the platform subscription.

Pricing tiers

Go-to-market motion3 records

Distribution channels2 records

Marketing channels8 records

Core offering

TransVoyant sells the Continuous Decision Intelligence™ (CDI) Platform, a deterministic, physics-based supply chain intelligence engine that ingests billions of daily global events and calculates exact, deterministic impacts on specific operations and shipments rather than probability scores. The platform enables predictive interdiction, autonomic rerouting and mode-shifting, and is paired with 24/7 Mission Services (White Glove Interdiction, Innovation Foundry, and IV&V Proving Ground) delivered globally across four Control Towers.

Product overview

TransVoyant offers the Continuous Decision Intelligence™ (CDI) Platform—a physics-based, deterministic supply chain intelligence system. The core CDI Nucleus™ engine processes billions of daily events using proprietary mathematical frameworks to model real-time supply chain behavior. The platform operates across four intelligence domains: Predictive Visibility & Risk (calculating exact disruption impacts), Precision Execution & Orchestration (automated interdiction), High Fidelity Continuous Optimization (real-time self-healing), and Adaptive Compliance & Sustainability (mathematical constraint enforcement). Mission Services provides human-led 24/7 overwatch including White Glove Interdiction, the Innovation Foundry for rapid application development, and the IV&V Proving Ground for hardware validation. The platform includes Network Intelligence with 13 years of inherited behavioral data and over 100 pre-built capability blades. The Precise Predictive Enterprise™ (P2E™) solution delivers the control tower view for end-to-end situational awareness.

Differentiator

Problem solved

Functional benefit

Quantifiable outcome

• 3 million+ vaccine doses saved for MSD through predictive interdiction
• +4 more outcomes

Named customers9 records

Segments5 records

Ideal customer profiles5 records

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability5 records

Feature8 records

Partnerships

One partnership is on record.

• EY-ParthenonminorStrategic or Co-development PartnerStrategy consulting partnership for thought leadership. EY-Parthenon co-authored paper with MSD on digital cold chain partnerships and participated in joint briefings on supply chain resilience. Relationship is content collaboration rather than commercial go-to-market partnership.

Scale indicators10 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Interos: Interos is an AI-driven supply chain risk intelligence platform providing continuous monitoring of supplier and operational risks. Comparable to TransVoyant in applying predictive analytics to multi-tier supply chain disruption, with overlap in defense and government customers.
• project44: project44 is a global supply chain visibility platform covering ocean, road, rail, air, and last-mile with a large carrier network. Direct competitor to TransVoyant in enterprise transportation visibility, with comparable Fortune 500 customer profile but a different go-to-market emphasizing carrier integrations over deterministic modeling.
• Resilinc: Resilinc is a supply chain risk management and resilience platform that maps multi-tier supplier networks and monitors disruption events. Closely comparable to TransVoyant's Predictive Visibility & Risk domain and defense/customer base overlap, with similar focus on Fortune 500 life sciences and industrials.
• FourKites: FourKites is a leading supply chain visibility platform offering real-time transportation visibility, predictive ETA, and yard management. Directly comparable to TransVoyant's CDI Platform in serving Fortune 500 shippers with predictive visibility, though FourKites emphasizes broader carrier-network-driven visibility versus TransVoyant's deterministic physics engine.

Broad incumbents

• SAP (Digital Supply Chain / IBP): SAP's Integrated Business Planning and Digital Supply Chain portfolio competes with TransVoyant at the enterprise tier. Comparable as a broad incumbent in supply chain intelligence and planning, with deep penetration among large manufacturers and life sciences companies.
• Coupa (formerly LLamasoft): Coupa acquired LLamasoft for supply chain design and network optimization, serving many of the same Fortune 500 manufacturers and life sciences customers. Comparable in network and scenario modeling capabilities, though focused on design versus real-time physics execution.
• Blue Yonder: Blue Yonder (formerly JDA) provides end-to-end supply chain planning, execution, and Luminate platform. Highly relevant incumbent given Tiffany Brewer's prior leadership of its Life Sciences vertical and overlapping pharma/medtech customer set with TransVoyant.
• Descartes Systems Group: Descartes is a global logistics technology and trade compliance provider with deep ocean, air, and customs offerings. Comparable broad incumbent in supply chain technology serving many of the same Fortune 500 shippers, particularly around international trade and visibility.
• E2open: E2open is a large connected supply chain platform spanning planning, logistics, and global trade management. Comparable broad incumbent serving similar Fortune 500 verticals with overlapping supply chain visibility and risk offerings, though as a much wider portfolio play.
• Kinaxis: Kinaxis offers the Maestro platform for concurrent supply chain planning, demand sensing, and orchestration. Comparable in serving Fortune 500 manufacturers and life sciences with supply chain intelligence, though focused on planning/optimization rather than real-time physical interdiction.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat7 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/transvoyant
• YouTubeyoutube.com/@transvoyant
• LinkedInlinkedin.com/company/transvoyant

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles10 records

Funding overview

Funding rounds4 records

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about TransVoyant